nav-left cat-right
cat-right

Protected: BIT’s 4th Annual Congress of Inte...

Conference Name: BIT’s 4th Annual Congress of International Drug Discovery Science & Technology 2006 (IDDST-2006) Date: May 25-Jun.2, 2006 Location: Dalian & Xi’an, China Theme: Combating Major Diseases for Happy Life Website: http://www.iddst.com Main Conference: Time: May 25-29, 2006 Venue: Dalian World Expo Center Satellite Meeting: Time: May 30-June 2, 2006 Venue: Conference Hall at Xi’an...

Dow AgroSciences Extends Research Collaboration wi...

Locus Pharmaceuticals, Inc., a computationally-based drug design and development company, announced today the continuation of its multi-stage research collaboration with Dow AgroSciences LLC, a subsidiary of The Dow Chemical Company (NYSE:DOW), focused on agrochemicals and biotechnology innovation. The collaboration involves the application of Locus’ proprietary computational technologies to design and develop novel...

KineMed Presents Innovative New Assays for Measure...

EMERYVILLE, Calif., Dec. 8, 2005 /PRNewswire/ — KineMed, Inc., a platform-based indications discovery and development drug company, announced today that two posters detailing results from a new product program will be presented at the World Congress on Osteoarthritis meeting to be held in Boston, MA from December 08, 2005-11th, 2005. The presentation information is as follows: Date: Friday,...

Evotec Reaches First Milestone and Receives Succes...

HAMBURG, Germany, December 06, 2005 /PRNewswire-FirstCall/ — Evotec AG announced today that the first milestone has been achieved in its four-year drug discovery collaboration with Takeda Pharmaceutical Company Limited (Osaka, Japan, “Takeda”). Evotec has granted Takeda exclusive rights in a novel target in Alzheimer’s disease based on successful target identification and validation work triggering a...

HUGIN NEWS/SENEXIS AND BIOFOCUS COLLABORATE TO SEL...

Galapagos service division BioFocus will use its medicinal chemistry capabilities to accelerate the optimisation of Senexis’ novel inhibitors of amyloid-induced toxicity and neuroinflammation Cambridge, UK, and Mechelen, Belgium, 2 December 2005 – Senexis Limited, a private drug development company, and Galapagos NV (Euronext & LSE: GLPG), a genomics based drug discovery company, announced today that they...

XIXth International Symposium on Medicinal Chemist...

Istanbul, Turkey – August 29 – September 2, 2006 The ISMC-2006 Symposium will be organized by the Turkish Association of Pharmaceutical and Medicinal Chemistry under the auspices of the European Federation for Medicinal Chemistry (EFMC). This symposium is recognized worldwide as one of the leading Medicinal Chemistry meetings, as proven by its large international attendance, which varies between 1200 and 1500...
Page 19 of 19« First...10...1516171819